A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors. A2 engineers T cells that target the loss of genetic material in tumors, enabling the selective killing of tumor cells while leaving normal cells unharmed. The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and has raised $136M since inception. Our investors include The Column Group, Vida Ventures, Samsara BioCapital, Nextech Invest, Casdin Capital, Euclidean Capital, UC Investments (Office of the Chief Investment Officer of the Regents) and Hartford HealthCare Endowment.



Sales & Business Development

westlake village, ca, usa

Agoura Hills, CA, USA

A2 Biotherapeutics

Therapeutics

S32 is a venture capital fund founded by Bill Maris.

Section 32, LLC

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Section 32 Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Section 32 network as they come up.

You can always update this information later.

Welcome to the Section 32 talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Section 32 company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Your professional information is now visible to our team and companies in our network.
We will be in touch when we find a great opportunity for you at one of our companies.

Thanks for signing up

As our companies grow, they look to us to help them find the best talent.
Signal that you'd be interested in working with a Section 32 company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.